Department of Ophthalmology, Kayseri City Education and Research Hospital, Kayseri, Turkey.
Department of Ophthalmology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
Klin Monbl Augenheilkd. 2022 Jun;239(6):799-803. doi: 10.1055/a-1720-1752. Epub 2022 Feb 18.
This study aimed to compare anatomical and functional outcomes of external dacryocystorhinostomy (EX-DCR) and transcanalicular multidiode laser dacryocystorhinostomy (TDL-DCR) in patients with primary acquired nasolacrimal duct obstruction (PANDO).
This study was conducted on 60 eyes of 60 patients with PANDO. The study subjects were randomly divided into two groups. Group 1 included 30 patients who underwent EX-DCR, and group 2 included 30 patients who underwent TDL-DCR. Surgery success rates were determined by patency of the neo-ostium, with free saline flow on irrigation and the absence of epiphora.
There were 23 women (76.7%) and 7 men (23.3%) with a mean age of 47.33 ± 12.44 years in group 1, and 18 women (60%) and 12 men (40%) with a mean age of 46.2 ± 19.4 years in group 2. There was no significant difference between groups 1 and 2 with respect to age or gender (p = 0.801, p = 0.267, respectively). The mean duration of symptoms was 3.2 years, ranging from 1.5 to 5 years. The mean postoperative follow-up was 12.3 ± 2.44 months. At the end of the follow-up period, the surgery success rates were 96.7% (29/30 eyes) in group 1, and 90% (27/30 eyes) in group 2. There was no statistical difference in the surgery success rates between groups (p = 0.612).
TDL-DCR is a minimally invasive and safe procedure. The lack of bleeding and incision scar and shorter operation time suggest that TDL-DCR can be a good alternative in PANDO patients.
本研究旨在比较原发性获得性鼻泪管阻塞(PANDO)患者行外鼻泪囊吻合术(EX-DCR)和经泪小管多二极管激光鼻泪囊吻合术(TDL-DCR)的解剖和功能结果。
本研究纳入了 60 例 PANDO 患者的 60 只眼。研究对象随机分为两组,组 1 为 30 例接受 EX-DCR 的患者,组 2 为 30 例接受 TDL-DCR 的患者。手术成功率通过新造口通畅、冲洗时有自由盐水流出且无溢泪来确定。
组 1 中,23 例女性(76.7%)和 7 例男性(23.3%),平均年龄为 47.33±12.44 岁,组 2 中,18 例女性(60%)和 12 例男性(40%),平均年龄为 46.2±19.4 岁。两组在年龄或性别方面无显著差异(p=0.801,p=0.267)。症状平均持续时间为 3.2 年,范围为 1.5 至 5 年。平均术后随访时间为 12.3±2.44 个月。在随访期末,组 1 的手术成功率为 96.7%(29/30 只眼),组 2 的手术成功率为 90%(27/30 只眼)。两组手术成功率无统计学差异(p=0.612)。
TDL-DCR 是一种微创且安全的手术方法。术中出血少、无切口瘢痕且手术时间短,提示 TDL-DCR 可作为 PANDO 患者的一种良好选择。